Patent · US Active

Proteasome inhibitors and methods of using the same

US7468383B2 · kind B2 · utility

2Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 9, 2006
Grant dateDec 23, 2008
Priority date
Expiry dateNov 9, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating diseases such as cancer and other disorders associated directly or indirectly with proteasome activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.